Keck Medicine Named New CEO Following Leadership Shift
The health system appointed Steven Shapiro as CEO, signaling a push to align clinical operations with academic research.
Updated on Oct. 12, 2026 in People
On Sept. 24, 2026, Steven Shapiro was named chief executive of Keck Medicine of USC, succeeding Rod Hanners. The transition coincides with a strategic restructuring intended to integrate operational oversight with the Keck School of Medicine.
Why it matters
By combining operational management with academic oversight, the university aims to accelerate innovation across its clinical footprint. This alignment reflects a broader strategy to bridge the gap between medical research and patient-facing healthcare delivery.
Keck Medicine operates 100 provider locations, and the new CEO previously led a system comprising over 40 hospitals. Rod Hanners concluded his tenure as chief executive following a 6-year term.
The players
Steven Shapiro
The newly appointed CEO of Keck Medicine who previously served as senior vice president for health affairs since 2021.
Rod Hanners
The former chief executive of Keck Medicine who completed a 6-year tenure before stepping down.
Marty Sargeant
The newly appointed COO of Keck Medicine who also continues his role as chief executive of Keck Medical Center of USC.
Carolyn Meltzer
The former dean of the Keck School of Medicine who resigned to become president of the Radiological Society of North America.
Vassilios Papadopoulos
The interim dean of the Keck School of Medicine who retains his role as dean of the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences.
The details
Steven Shapiro will maintain his position as senior vice president for health affairs while assuming the CEO role. Simultaneously, the organization appointed Marty Sargeant as chief operating officer, while Vassilios Papadopoulos was named interim dean of the Keck School of Medicine. This consolidation is designed to unify administrative control to drive clinical efficiency across the system's locations in Los Angeles, Orange, Kern, Tulare, and Ventura counties, as well as Las Vegas.
Timeline
2021: Steven Shapiro joined USC as senior vice president.
Sept. 24, 2026: Rod Hanners stepped down as CEO of Keck Medicine.
Market Landscape
The appointment follows an industry-wide trend of consolidating academic and clinical leadership to improve translational research speeds. This move marks a shift toward tighter integration of the university's research capabilities and its expanding clinical provider network.
Operators should monitor the integration of administrative roles, as such shifts often precede changes in procurement or service-line prioritization. Evaluating vendor contracts for alignment with a consolidated health system remains a priority for partners in the region.
The takeaway
The move signals that USC is prioritizing internal synergy over siloed leadership structures to scale its regional health operations. Leaders in the space should watch for how this consolidated oversight impacts vendor vetting and operational expansion into areas like Pasadena.
Further reading
For more on local leadership changes, visit People.
Source note: This article includes information reported by Los Angeles Business Journal.
